These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37165436)

  • 41. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0.
    Sawadogo S; Shiningavamwe A; Chang J; Maher AD; Zhang G; Yang C; Gaeb E; Kaura H; Ellenberger D; Lowrance DW
    J Clin Microbiol; 2014 Nov; 52(11):3878-83. PubMed ID: 25143579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care.
    Agutu CA; Ngetsa CJ; Price MA; Rinke de Wit TF; Omosa-Manyonyi G; Sanders EJ; Graham SM
    PLoS One; 2019; 14(6):e0218369. PubMed ID: 31246963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Roche CAP/CTM HIV-1 qualitative test version 2.0 using dried blood spots for early infant diagnosis.
    Gueye SB; Diop-Ndiaye H; Diallo MM; Ly O; Sow-Ndoye A; Diagne-Gueye ND; Kébé-Fall K; Diop F; Gaye-Diallo A; Belec L; Mboup S; Touré-Kane C
    J Virol Methods; 2016 Mar; 229():12-5. PubMed ID: 26706730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classification of HIV-1 virological treatment failure using the Roche cobas plasma separation card on cobas 8800 compared to dried blood spots on Abbott RealTime HIV-1.
    Hans L; Marins EG; Simon CO; Magubane D; Seiverth B; Carmona S
    J Clin Virol; 2021 Jul; 140():104839. PubMed ID: 33991979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B viral load in dried blood spots: A validation study in Zambia.
    Vinikoor MJ; Zürcher S; Musukuma K; Kachuwaire O; Rauch A; Chi BH; Gorgievski M; Zwahlen M; Wandeler G
    J Clin Virol; 2015 Nov; 72():20-4. PubMed ID: 26356987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform.
    Thepbundit V; Ngo-Giang-Huong N; Salvadori N; Laolue A; Kunyanone N; Sata-Un J; Jourdain G; Sirirungsi W; Khamduang W
    J Med Virol; 2019 Sep; 91(9):1652-1659. PubMed ID: 31095748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 load with the NucliSENS Easy-Q HIV-1 version 2.0 assay in Malawi.
    Fajardo E; Metcalf CA; Chaillet P; Aleixo L; Pannus P; Panunzi I; Triviño L; Ellman T; Likaka A; Mwenda R
    J Clin Microbiol; 2014 May; 52(5):1343-51. PubMed ID: 24501032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
    Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.
    Lofgren SM; Morrissey AB; Chevallier CC; Malabeja AI; Edmonds S; Amos B; Sifuna DJ; von Seidlein L; Schimana W; Stevens WS; Bartlett JA; Crump JA
    AIDS; 2009 Nov; 23(18):2459-66. PubMed ID: 19741481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis.
    Vojnov L; Carmona S; Zeh C; Markby J; Boeras D; Prescott MR; Mayne ALH; Sawadogo S; Adje-Toure C; Zhang G; Perez Gonzalez M; Stevens WS; Doherty M; Yang C; Alexander H; Peter TF; Nkengasong J;
    PLoS Med; 2022 Aug; 19(8):e1004076. PubMed ID: 35994520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load.
    Adams P; Vancutsem E; Nicolaizeau C; Servais JY; Piérard D; François JH; Schneider T; Paxinos EE; Marins EG; Canchola JA; Seguin-Devaux C
    J Clin Virol; 2019 May; 114():43-49. PubMed ID: 30991164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the Gen-Probe Aptima HIV-1 and Abbott HIV-1 qualitative assays with the Roche Amplicor HIV-1 DNA assay for early infant diagnosis using dried blood spots.
    Nelson JA; Hawkins JT; Schanz M; Mollan K; Miller MB; Schmitz JL; Fiscus SA
    J Clin Virol; 2014 Aug; 60(4):418-21. PubMed ID: 24929752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples.
    Lakhal-Naouar I; Hack HR; Moradel E; Jarra A; Grove HL; Ismael RM; Padilla S; Coleman D; Ouellette J; Darden J; Storme C; Peachman KK; Hall TL; Huhtanen ME; Scott PT; Hakre S; Jagodzinski LL; Peel SA
    PLoS One; 2023; 18(6):e0287576. PubMed ID: 37384714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    Kamble S; Shidhaye P; Mukherjee A; Tak M; Bembalkar S; Aggarwal S; Deb A; Kapoor N; Verma V; Das C; Kulkarni S; Ghate M; Godbole S
    PLoS One; 2023; 18(5):e0285942. PubMed ID: 37200292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples.
    Schalasta G; Börner A; Speicher A; Enders M
    Clin Chem Lab Med; 2018 Mar; 56(4):634-641. PubMed ID: 29197859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with
    Sberna G; Sarti S; Cicalini S; Antinori A; Garbuglia AR; Amendola A
    Microbiol Spectr; 2022 Oct; 10(5):e0136122. PubMed ID: 36066258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe.
    Napierala Mavedzenge S; Davey C; Chirenje T; Mushati P; Mtetwa S; Dirawo J; Mudenge B; Phillips A; Cowan FM
    PLoS One; 2015; 10(5):e0126878. PubMed ID: 26001044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples.
    Catlett B; Bajis S; Starr M; Dore GJ; Hajarizadeh B; Cunningham PH; Applegate TL; Grebely J
    J Infect Dis; 2021 Mar; 223(5):818-826. PubMed ID: 32710758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.